Insulin Sensitivity and Metabolism Before and After Treatment in Patients With Hypothyroidism
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Aarhus, Denmark, 8000
- Medical department M (Endocrinology and Diabetes), Aarhus University Hospital, Aarhus Sygehus,
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- written informed consent
- must be of legal age and competent
- Age > 18 years
- presently diagnosed with hypothyroidism
Exclusion Criteria:
- alcohol consumption >21 units per week
- Malignant disease
- pregnancy
- magnetic implants or material in the body
- BMI > 30
- Heart disease (NYHA >2)
- Uncontrolled hypertension
- Manifest diabetes mellitus
- Changes in medication, with any influence on glucose metabolism, 2 months prior to and until the end of the trial.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
EXPERIMENTAL: 1
the aim of the present study is to characterize the treatment related changes in insulin sensitivity, substrate metabolism and intrahepatic - intramyocellular lipids in 12 adult patients, recently diagnosed with hypothyroidism
|
Dosage regulation will follow the local recommendations of treatment
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
intracellular lipid content in liver and muscle
Time Frame: before and after 3 months treatment with growth hormone
|
before and after 3 months treatment with growth hormone
|
|
intraabdominal lipid content
Time Frame: before and after treatment
|
before and after treatment
|
|
insulin sensitivity
Time Frame: before and after treatment
|
before and after treatment
|
|
substrate metabolism
Time Frame: before and after treatment
|
before and after treatment
|
|
intracellular signaling in the basal state and during insulin stimulation
Time Frame: before and after treatment
|
before and after treatment
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (ANTICIPATED)
Primary Completion
Study Completion (ANTICIPATED)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- LM_HYPO_2008
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.